XML 87 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued operations - Schedule of Statement of Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Loss on deconsolidation $ 60,639  
Non-refundable payments 10,150  
Disposed of by Sale | Carti Heal    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Selling, general and administrative expense 1,728 $ 0
Research and development expense 396 0
Change in fair value of contingent consideration 1,710 0
Depreciation and amortization 4,264 0
Operating loss from discontinued operations (8,098) 0
Interest expense (income), net 4,889 0
Other expense 61,442 401
Other expense (income) 66,331 401
Net loss (74,429) (401)
Loss attributable to noncontrolling interest 14,937 0
Net loss attributable to Bioventus Inc. $ (59,492) $ (401)